Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ranitidine, sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is used in the treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein.
History, Applications, Products & Standards
Explore the main themes, entities and connections around Ranitidine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ndma 2019 may drug medicines products h2 fda united levels found 2020 risk states receptor recalled effects drugs issued zantac
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ranitidine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ranitidine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Ranitidine | ATC code | A02BA02 (WHO) A02BA07 (WHO) (ranitidine bismuth citrate) | 1.00 | infobox |
| Ranitidine | Bioavailability | 50% (by mouth) | 1.00 | infobox |
| Ranitidine | CAS Number | 66357-35-5 | 1.00 | infobox |
| Ranitidine | CAS Number | HCl: 66357-59-3 | 1.00 | infobox |
| Ranitidine | ChEBI | CHEBI:8776 | 1.00 | infobox |
| Ranitidine | ChEBI | HCl: CHEBI:8777 | 1.00 | infobox |
| Ranitidine | ChEMBL | ChEMBL1790041 | 1.00 | infobox |
| Ranitidine | ChEMBL | HCl: ChEMBL2110372 | 1.00 | infobox |
| Ranitidine | ChemSpider | 4863 | 1.00 | infobox |
| Ranitidine | ChemSpider | HCl: 43590 | 1.00 | infobox |
| Ranitidine | CompTox Dashboard (EPA) | DTXSID8045191 | 1.00 | infobox |
| Ranitidine | Drug class | Histamine H2 receptor antagonist, aka H2 blocker | 1.00 | infobox |
| Ranitidine | DrugBank | DB00863 | 1.00 | infobox |
| Ranitidine | DrugBank | HCl: DBSALT000487 | 1.00 | infobox |
| Ranitidine | ECHA InfoCard | 100.060.283 | 1.00 | infobox |
| Ranitidine | Elimination half-life | 2–3 hours | 1.00 | infobox |
| Ranitidine | Excretion | 30–70% kidney | 1.00 | infobox |
| Ranitidine | Formula | C13H22N4O3S | 1.00 | infobox |
| Ranitidine | IUPHAR/BPS | 1234 | 1.00 | infobox |
| Ranitidine | KEGG | D00422 | 1.00 | infobox |
| Ranitidine | KEGG | HCl: D00673 | 1.00 | infobox |
| Ranitidine | Legal status | AU: S4 (Prescription only) / S2 (Pharmacy Medicine) | 1.00 | infobox |
| Ranitidine | Legal status | CA: ℞-only / OTC | 1.00 | infobox |
| Ranitidine | Legal status | US: ℞-only / OTC | 1.00 | infobox |
| Ranitidine | Legal status | EU: Rx-only | 1.00 | infobox |
| Ranitidine | License data | US DailyMed: Ranitidine | 1.00 | infobox |
| Ranitidine | MedlinePlus | a601106 | 1.00 | infobox |
| Ranitidine | Metabolism | Liver: FMOs, including FMO3; other enzymes | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.